OTCMKTS:SYZLF Sylogist (SYZLF) Stock Price, News & Analysis → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free SYZLF Stock Alerts $6.53 -0.26 (-3.83%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$6.53▼$6.5650-Day Range$6.29▼$7.3352-Week Range$4.15▼$7.33Volume400 shsAverage Volume6,016 shsMarket CapitalizationN/AP/E Ratio46.64Dividend Yield3.14%Price TargetN/A Stock AnalysisStock AnalysisChartShort InterestStock AnalysisChartShort Interest Get Sylogist alerts: Email Address Ad Insider FinancialThousands of investors use this no cost solution | Do you? In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.Simply tap here now to subscribe and start getting "Insider Financial Advantage" About Sylogist Stock (OTCMKTS:SYZLF)Sylogist Ltd., a software company, provides software-as-a-service solutions in Canada, the United States, and the United Kingdom. The company manages IT services, business applications, and Web portals. The company was incorporated in 1993 and is headquartered in Calgary, Canada.Read More SYZLF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SYZLF Stock News HeadlinesMarch 14, 2024 | globenewswire.comSylogist Reports Record Fourth Quarter and Full Year 2023 ResultsFebruary 23, 2024 | globenewswire.comSylogist Acquires Innovative Time Tracking & Scheduling SaaS Solution for its Gov, Ed and Mission PlatformsApril 25, 2024 | Behind the Markets (Ad)The World's First "$20 Trillion Drug?"One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!February 16, 2024 | globenewswire.comSylogist Declares Quarterly DividendDecember 16, 2021 | ca.finance.yahoo.comWhy Sylogist Stock Price Soared 10% YesterdayDecember 14, 2021 | ca.finance.yahoo.comSylogist Ltd. (SYZLF)December 8, 2021 | ca.finance.yahoo.comSylogist to Discuss Fiscal 2021 and Q4 PerformanceNovember 18, 2021 | yahoo.comSylogist Declares Quarterly DividendApril 25, 2024 | Behind the Markets (Ad)The World's First "$20 Trillion Drug?"One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!October 19, 2021 | apnews.comIT ExchangeNet Facilitates pavliks.com’s Acquisition by SylogistOctober 12, 2021 | finance.yahoo.comSylogist (TSE:SYZ) Has More To Do To Multiply In Value Going ForwardOctober 7, 2021 | finance.yahoo.comSylogist Acquires Innovative SaaS Fundraising PlatformSeptember 16, 2021 | finance.yahoo.comThe past three years for Sylogist (TSE:SYZ) investors has not been profitableSee More Headlines Receive SYZLF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sylogist and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings1/15/2014Today4/25/2024Next Earnings (Estimated)5/06/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorComputer and Technology Industry Software - Application Sub-IndustryN/A Current SymbolOTCMKTS:SYZLF CUSIPN/A CIKN/A Webwww.sylogist.com Phone(403) 266-4808FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio48.50 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. William C. Wood (Age 61)President, CEO & Non-Independent Director Comp: $775.03kMr. Xavier Shorter (USA)and CPA, CA (Canada), CPA, VP of Finance & OperationMs. Theresa LoPrestiChief Technology & Innovation OfficerMr. Sujeet Kini (Age 62)Chief Financial Officer Mr. Rudy ShirraManager of Corporate Development & Investor RelationsMs. Donna SmileyChief Customer OfficerMr. Grant McLarnonChief Revenue OfficerMs. Malgorzata LewandowskiCorporate Controller & TreasurerMs. Tracy HarderVP of Talent & EngagementMore ExecutivesKey Competitors01 Communique LaboratoryOTCMKTS:OCQLFaccesso Technology GroupOTCMKTS:LOQPFAdacel TechnologiesOTCMKTS:AELTFAdvanced Credit TechnologiesOTCMKTS:ACRTAdvantegoOTCMKTS:ADGOView All Competitors SYZLF Stock Analysis - Frequently Asked Questions How have SYZLF shares performed in 2024? Sylogist's stock was trading at $5.6463 at the start of the year. Since then, SYZLF stock has increased by 15.7% and is now trading at $6.53. View the best growth stocks for 2024 here. Are investors shorting Sylogist? Sylogist saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 18,200 shares, an increase of 50.4% from the March 31st total of 12,100 shares. Based on an average trading volume of 1,800 shares, the short-interest ratio is presently 10.1 days. View Sylogist's Short Interest. When is Sylogist's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 6th 2024. View our SYZLF earnings forecast. How were Sylogist's earnings last quarter? Sylogist Ltd. (OTCMKTS:SYZLF) released its quarterly earnings results on Wednesday, January, 15th. The company reported $0.08 earnings per share (EPS) for the quarter. Is Sylogist a good dividend stock? Sylogist (OTCMKTS:SYZLF) pays an annual dividend of $0.21 per share and currently has a dividend yield of 2.39%. The dividend payout ratio is 146.43%. Payout ratios above 75% are not desirable because they may not be sustainable. How do I buy shares of Sylogist? Shares of SYZLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:SYZLF) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe AI stock to buy right nowStockEarningsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsI’m afraid WWIII is a very real possibility Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sylogist Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.